tiprankstipranks
Trending News
More News >
Bright Minds Biosciences (TSE:DRUG)
:DRUG
Canadian Market
Advertisement

Bright Minds Biosciences (DRUG) Financial Statements

Compare
67 Followers

Bright Minds Biosciences Financial Overview

Bright Minds Biosciences's market cap is currently C$530.57M. The company's EPS TTM is C$-0.74; its P/E ratio is ―; Bright Minds Biosciences is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is C$-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Bright Minds Biosciences Debt to Assets

Bright Minds Biosciences Cash Flow

Bright Minds Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis